| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10135-692-01 | 10135-692 | HUMAN PRESCRIPTION DRUG | Amantadine Hydrochloride | Amantadine Hydrochloride | TABLET | ORAL | 20200301 | N/A | ANDA | ANDA210215 | Marlex Pharmaceuticals Inc | AMANTADINE HYDROCHLORIDE | 100 mg/1 | 100 TABLET in 1 BOTTLE (10135-692-01) |
| 10135-692-05 | 10135-692 | HUMAN PRESCRIPTION DRUG | Amantadine Hydrochloride | Amantadine Hydrochloride | TABLET | ORAL | 20200301 | N/A | ANDA | ANDA210215 | Marlex Pharmaceuticals Inc | AMANTADINE HYDROCHLORIDE | 100 mg/1 | 500 TABLET in 1 BOTTLE (10135-692-05) |
| 24689-112-01 | 24689-112 | HUMAN PRESCRIPTION DRUG | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET | ORAL | 20240601 | N/A | ANDA | ANDA210215 | Apnar Pharma LP | AMANTADINE HYDROCHLORIDE | 100 mg/1 | 100 TABLET in 1 BOTTLE (24689-112-01) |
| 24689-112-02 | 24689-112 | HUMAN PRESCRIPTION DRUG | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET | ORAL | 20240601 | N/A | ANDA | ANDA210215 | Apnar Pharma LP | AMANTADINE HYDROCHLORIDE | 100 mg/1 | 500 TABLET in 1 BOTTLE (24689-112-02) |